Takeda Pharmaceutical Co (MEX:TAK) Issuance of Debt : MXN144,299 Mil (TTM As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co Issuance of Debt?

Takeda Pharmaceutical Co's Issuance of Debt for the three months ended in Sep. 2024 was MXN65,677 Mil.

Takeda Pharmaceutical Co's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was MXN144,299 Mil.

Takeda Pharmaceutical Co Issuance of Debt Historical Data

The historical data trend for Takeda Pharmaceutical Co's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Issuance of Debt Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Issuance of Debt

Get a 7-Day Free Trial

108,061.25

221,809.25

41,867.08

15,508.07

41,762.43

Takeda Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Issuance of Debt	Get a 7-Day Free Trial															-	20,041.62	-332.33	58,912.84	65,676.85

Takeda Pharmaceutical Co Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN144,299 Mil.

Takeda Pharmaceutical Co Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (MEX:TAK) » Definitions » Issuance of Debt

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA 4502:Japan 0A87:UK TKDA:Germany TAKP34:Brazil TKD:Austria

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.